Clinical Trial Update: Continued Treatment for Participants Enrolled in Studies of BXQ-350 [Phase 1]

View source ↗

Summary

An update on BXQ-350 Phase 1 studies notes termination of the trials, with continued treatment for currently enrolled participants.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neoplasms

Drugs mentioned

• BXQ-350

Snippet

Sponsor: Bexion Pharmaceuticals, Inc. | Conditions: Neoplasms | Phase 1 | Status: TERMINATED